Table 3

Hepatitis C virus (HCV) RNA clearance rates

HCV RNA clearance rates by PCR
Intention to treat analysis (n = 171)Response among those who completed 24 weeks of therapy (n = 136)
AmantadinePlacebop ValueAmantadinePlacebop Value
PCR, polymerase chain reaction; SVR, sustained viral response; ETR, end of treatment response.
24 wks during treatment40.0% (n = 34)45.3% (n = 39)0.349.3% (n = 34)56.5% (n = 39)0.2
ETR at 48 wks32.9% (n = 28)38.4% (n = 33)0.340.6% (n = 28)47.8% (n = 33)0.2
SVR at 24 wks post-treatment24.7% (n = 21)27.9% (n = 24)0.430.4% (n = 21)34.8% (n = 24)0.4